• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pro-Con Perspectives on Ethics in Surgical Research: Update from the 39th Annual Surgical Infection Society Meeting.外科研究伦理的正反观点:第 39 届外科感染学会年会更新。
Surg Infect (Larchmt). 2020 May;21(4):332-343. doi: 10.1089/sur.2020.098.
2
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
Ethical issues in surgical research.外科研究中的伦理问题。
Thorac Surg Clin. 2005 Nov;15(4):543-54. doi: 10.1016/j.thorsurg.2005.06.008.
4
Is a placebo-controlled surgical trial an oxymoron?安慰剂对照的外科手术试验是一种矛盾修饰法吗?
J Minim Invasive Gynecol. 2007 May-Jun;14(3):278-83. doi: 10.1016/j.jmig.2006.12.006.
5
American Society of Clinical Oncology policy statement: oversight of clinical research.美国临床肿瘤学会政策声明:临床研究监督
J Clin Oncol. 2003 Jun 15;21(12):2377-86. doi: 10.1200/JCO.2003.04.026. Epub 2003 Apr 29.
6
Variability in research ethics review of cluster randomized trials: a scenario-based survey in three countries.整群随机试验的研究伦理审查中的差异:三个国家基于情景的调查
Trials. 2014 Feb 5;15:48. doi: 10.1186/1745-6215-15-48.
7
Ethical considerations and barriers to research in surgical palliative care.外科姑息治疗研究中的伦理考量与障碍
J Am Coll Surg. 2003 Mar;196(3):469-74. doi: 10.1016/S1072-7515(02)01890-2.
8
Inadequacy of ethical conduct and reporting of stepped wedge cluster randomized trials: Results from a systematic review.阶梯楔形整群随机试验的伦理行为及报告存在不足:一项系统评价的结果
Clin Trials. 2017 Aug;14(4):333-341. doi: 10.1177/1740774517703057. Epub 2017 Apr 8.
9
A Proposed Road Map for the Ethical Evaluation of Sham (Placebo) Surgery.一份关于假手术(安慰剂手术)伦理评估的拟议路线图。
Ann Surg. 2017 Apr;265(4):658-661. doi: 10.1097/SLA.0000000000002007.
10
[Some recent ethical dilemmas in randomized controlled clinical trials].[随机对照临床试验中近期出现的一些伦理困境]
Orv Hetil. 2008 Sep 14;149(37):1753-60. doi: 10.1556/OH.2008.28431.

本文引用的文献

1
Short-term impact of introducing a soft opt-out organ donation system in Wales: before and after study.威尔士引入软性自愿器官捐献制度的短期影响:前后研究。
BMJ Open. 2019 Apr 3;9(4):e025159. doi: 10.1136/bmjopen-2018-025159.
2
A Roadmap for Aspiring Surgeon-Scientists in Today's Healthcare Environment.今日医疗环境下,有志于成为外科医生科学家的路线图。
Ann Surg. 2019 Jan;269(1):66-72. doi: 10.1097/SLA.0000000000002840.
3
Patients' experiences and preferences for opt-in models and health professional involvement in biobanking consent: A cross-sectional survey of Australian cancer outpatients.患者对选择加入模式以及医疗专业人员参与生物样本库同意过程的体验和偏好:一项针对澳大利亚癌症门诊患者的横断面调查。
Asia Pac J Clin Oncol. 2019 Feb;15(1):31-37. doi: 10.1111/ajco.12866. Epub 2018 Mar 23.
4
Pharmaceutical company spending on research and development and promotion in Canada, 2013-2016: a cohort analysis.2013 - 2016年加拿大制药公司在研发与推广方面的支出:一项队列分析
J Pharm Policy Pract. 2018 Mar 13;11:5. doi: 10.1186/s40545-018-0132-3. eCollection 2018.
5
Contribution of NIH funding to new drug approvals 2010-2016.NIH 资助对 2010-2016 年新药批准的贡献。
Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):2329-2334. doi: 10.1073/pnas.1715368115. Epub 2018 Feb 12.
6
Acceptability of opt-out consent in a hospital patient population.医院患者群体中选择退出同意的可接受性。
Intern Med J. 2018 Jan;48(1):84-87. doi: 10.1111/imj.13666.
7
The rise and fall of an opt-out system.退出选择系统的兴衰。
Scand J Public Health. 2020 Jun;48(4):400-404. doi: 10.1177/1403494817745189. Epub 2017 Dec 5.
8
Considerations and guidance in designing equity-relevant clinical trials.考虑因素和指导意见在设计与公平相关的临床试验中。
Int J Equity Health. 2017 Jun 5;16(1):93. doi: 10.1186/s12939-017-0591-1.
9
Data Check: Federal share of basic research hits new low.数据核查:联邦政府在基础研究中的份额降至新低。
Science. 2017 Mar 10;355(6329):1005. doi: 10.1126/science.355.6329.1005.
10
Relativity in the Global Positioning System.全球定位系统中的相对论
Living Rev Relativ. 2003;6(1):1. doi: 10.12942/lrr-2003-1. Epub 2003 Jan 28.

外科研究伦理的正反观点:第 39 届外科感染学会年会更新。

Pro-Con Perspectives on Ethics in Surgical Research: Update from the 39th Annual Surgical Infection Society Meeting.

机构信息

Department of Surgery, MetroHealth Medical Center, Cleveland, Ohio, USA.

Department of Quantitative and Population Health Sciences, Case Western Reserve University, Cleveland, Ohio, USA.

出版信息

Surg Infect (Larchmt). 2020 May;21(4):332-343. doi: 10.1089/sur.2020.098.

DOI:10.1089/sur.2020.098
PMID:32364879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7232654/
Abstract

Surgical research is potentially invasive, high-risk, and costly. Research that advances medical dogma must justify both its ends and its means. Although ethical questions do not always have simple answers, it is critically important for the clinician, researcher, and patient to approach these dilemmas and surgical research in a thoughtful, conscientious manner. We present four ethical issues in surgical research and discuss the opposing viewpoints. These topics were presented and discussed at the 39th Annual Meeting of the Surgical Infection Society as pro-con debates. The presenters of each opinion developed a succinct summary of their respective reviews for this publication. The key subjects for these pro-con debates were: (1) Should patients be enrolled for time-sensitive surgical infection research using an opt-out or an opt-in strategy? (2) Should patients who are being enrolled in a randomized controlled trial (RCT) comparing surgery with a non-operative intervention pay the costs of their treatment arm? (3) Should the scientific community embrace open access journals as the future of scientific publishing? (4) Should the majority of funding go to clinical or basic science research? Important points were illustrated in each of the pro-con presentations and illustrated the difficulties that are facing the performance and payment of infection research in the future. Surgical research is ethically complex, with conflicting demands between individual patients, society, and healthcare economics. At present, there are no clear answers to these and the many other ethical issues facing research in the future. Answers will only come from continued robust dialogue among all stakeholders in surgical research.

摘要

外科研究具有潜在的侵袭性、高风险性和高成本。推进医学教条的研究必须证明其目的和手段都是合理的。尽管伦理问题并不总是有简单的答案,但临床医生、研究人员和患者以深思熟虑、认真负责的态度来处理这些困境和外科研究至关重要。我们提出了外科研究中的四个伦理问题,并讨论了对立的观点。这些主题是在外科感染学会第 39 届年会上作为正反双方辩论提出和讨论的。每个观点的陈述者都为本次出版物编写了各自观点的简明摘要。这些正反双方辩论的主要议题是:(1) 对于使用默认同意或知情同意策略进行时间敏感的外科感染研究,是否应该招募患者?(2) 正在参与比较手术与非手术干预的随机对照试验 (RCT) 的患者是否应该支付其治疗组的费用?(3) 科学界是否应该接受开放获取期刊作为未来的科学出版方式?(4) 大部分资金应该投向临床还是基础科学研究?正反双方的陈述都强调了每个议题的要点,并说明了未来感染研究在实施和支付方面所面临的困难。外科研究在伦理上是复杂的,在个体患者、社会和医疗保健经济学之间存在相互冲突的需求。目前,对于这些问题以及未来研究面临的许多其他伦理问题,没有明确的答案。答案只能来自外科研究所有利益相关者之间持续的强有力对话。